Increased expressions of Wnt ligands, including Wnt-5a and Wnt-11, are shown in primary prostate cancer tissues and bone-metastasis lesions, and elevated Wnt-11 expression is correlated with PSA levels and implicated in neuroendocrine (NE) transdifferentiation [17, 18]. This evidence concerns the gene WNT5A and prostate carcinoma.